entrezID,gene_symbol,biotype,bioproject,res_design,host_type,stimulator,concentration,H.P.S,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,cell_type
645332,FAM86C2P,transcribed_pseudogene,PRJNA474093,IFN-beta stimulation vs. mock stimulation,immortalized human hepatocytes PH5CH8,IFN-beta,N.A.,12,59.7396239492559,0.0422651030943578,0.259688740797422,0.162752928619759,0.870712971511626,0.979797069951312,NA
645332,FAM86C2P,transcribed_pseudogene,PRJNA565586,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,100U/ml,24,97.9338947341208,-0.414924963938191,0.190325302329064,-2.18008304130159,0.0292513066045019,0.176135369310831,patient-derived GBM cell lines (PDGCLs)
645332,FAM86C2P,transcribed_pseudogene,PRJNA667475,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,250U/ml,8,160.038422286643,-0.339856030597748,0.165359701795603,-2.05525304477045,0.0398545700531453,0.166231127109219,A549
645332,FAM86C2P,transcribed_pseudogene,PRJNA739760,INF-alpha2 stimulation (with DMSO) vs. mock stimulation (with DMSO),NA,IFN-alpha,1000U/ml,16,127.497579353282,-0.250502688534748,0.190123760987242,-1.3175769679391,0.187645299916341,0.98197055436858,A549
645332,FAM86C2P,transcribed_pseudogene,PRJNA768480,IFN-gamma stimulation vs. mock stimulation,NA,IFN-gamma,N.A.,N.A.,383.276827238262,0.169036677843814,0.171546663721633,0.98536849494262,0.324443099088562,0.629436458463059,A549
645332,FAM86C2P,transcribed_pseudogene,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,220.508763379939,0.0445772756073659,0.201434985937303,0.221298576312065,0.824859958443271,1,sigmoid colon organoid
645332,FAM86C2P,transcribed_pseudogene,PRJNA788896,IFN-beta stimulation vs. mock stimulation,NA,IFN-beta,N.A.,N.A.,220.508763379939,0.211354981740622,0.2003040404628,1.05517083555723,0.29134719995176,1,sigmoid colon organoid
